Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Other Non-Current Assets (2020 - 2025)

Sotera Health (SHC) has 6 years of Other Non-Current Assets data on record, last reported at $53.8 million in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 26.56% year-over-year to $53.8 million; the TTM value through Dec 2025 reached $53.8 million, up 26.56%, while the annual FY2025 figure was $53.8 million, 26.56% up from the prior year.
  • Other Non-Current Assets reached $53.8 million in Q4 2025 per SHC's latest filing, up from $37.6 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $53.8 million in Q4 2025 and bottomed at $5.5 million in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $29.5 million, with a median of $36.3 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: tumbled 41.12% in 2021, then surged 611.63% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $5.5 million in 2021, then soared by 611.63% to $39.0 million in 2022, then decreased by 26.94% to $28.5 million in 2023, then surged by 49.3% to $42.5 million in 2024, then increased by 26.56% to $53.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $53.8 million in Q4 2025, $37.6 million in Q3 2025, and $39.3 million in Q2 2025.